<DOC>
	<DOCNO>NCT01896739</DOCNO>
	<brief_summary>To evaluate compare immunogenicity Eutravac ( Diphtheria-Tetanus-acellular Pertussis [ DTaP ] Hepatitis B [ HB ] combine ) vaccine separate simultaneous administration DTaP HB vaccine administer healthy infant , measure seroprotection/vaccine response rate 4-8 week post-final immunisation .</brief_summary>
	<brief_title>A Phase III Study Assess Immunogenicity Safety Eutravac ( DTap-HB Combined Vaccine ) With DTaP Hepatitis B Vaccines Healthy Infants</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Were healthy , male female infant bear full term pregnancy ( ≥37 week ) birth weight ≥2.5 kg mother negative HBsAg serology , document prior give birth per routine , sitespecific antenatal care procedure . Signed parental legally acceptable representative 's informed consent obtain Evidence acute febrile illness axillary temperature ≥37.5℃ day vaccination . Infants symptom minor illness eg , mild gastroenteritis , mild upper respiratory tract infection temperature ≥37.5℃ day vaccination could include Investigator 's discretion History diphtheria , tetanus , pertussis hepatitis B disease History vaccinerelated hypersensitivity anaphylactic reaction previous administration Euvax B</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>6 Months</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Healthy infant 37 week gestation period .</keyword>
	<keyword>2.5Kg birth weight .</keyword>
</DOC>